ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAV NAVCO Pharmaceuticals Inc

0.035
-0.005 (-12.50%)
25 Jun 2024 - Closed
Delayed by 15 minutes

NAVCO Pharmaceuticals Financial Summary

The current NAV market cap is 1.41M. The company's latest EPS is CAD -0.0532 and P/E is -0.56.

Year End 30 September 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -185k00-1,000-347k
Net Income -185k-49k-74k-94k-2.15M
Year End 30 September 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 231k181k116k112k931k
Total Liabilities 21k20k18k109k844k
Total Equity 210k161k98k3k87k

Cash Flow

Year End 30 September 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -89k-48k-81k-10k-1.78M
Investing N/A N/A N/A N/A N/A
Financing 271k25k-88k N/A 2.01M
Market Cap 1.41M
Price to Earnings Ratio -0.56
Price to Sales Ratio 0
Price to Cash Ratio 5.17
Price to Book Ratio 13.91
Dividend Yield -

Share Statistics

Shares Outstanding 40.35M
Average Volume (1 week) 20.83k
Average Volume (1 Month) 82.74k
52 Week Change -36.36%
52 Week High 0.115
52 Week Low 0.02
Spread (Intraday) 0.02 (30%)

Company Info

Company Name NAVCO Pharmaceuticals Inc
Address 5205 harvester road, unit 1
burlington, ontario L7L 6B5
Website https://navcopharma.com
Industry unit inv tr, closed-end mgmt (6726)

Your Recent History

Delayed Upgrade Clock